Lv7
4680 积分 2024-02-04 加入
Strategies for targeting cytokines in inflammatory bowel disease
3天前
已完结
High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis
3天前
已完结
AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial
13天前
已完结
Anti-TNF-α therapies for the treatment of Crohn’s disease: the past, present and future
13天前
已完结
Development of lipoprotein(a) siRNAs for mechanism of action studies in non-human primate models of atherosclerosis
1个月前
已完结
Refractory gout: what is it and what to do about it?
1个月前
已完结
Emerging therapeutic options for refractory gout
1个月前
已完结
Role of megalin and the soluble form of its ligand RAP in Cd-metallothionein endocytosis and Cd-metallothionein-induced nephrotoxicity in vivo
1个月前
已完结
Dominant thermodynamic role of the third independent receptor binding site in the receptor-associated protein RAP
1个月前
已完结
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting
1个月前
已完结
皖公网安备34019202002308
